Author
Harvard UniversityORCID 0000-0001-5288-9110Unclaimed ORCID profile · follow to get notified of new preprints
Mutual co-authors in cluster
3 papers
Recent·Most cited
Hongyan Xie, Aiping Jiang, Aonkon Dey…·Russell William Jenkins
This study identifies a novel CD8+ TIL subset that uses lymphotoxin and IFN pathways to kill cancer cells, linking LTB expression to clinical response in melanoma.
Or‐Yam Revach, Angelina M. Cicerchia, Ofir Shorer…·Russell William Jenkins
This study shows that targeting CD38 improves T cell function and restores response to immunotherapy in melanoma models.
Samuel S. Freeman, Moshe Sade-Feldman, Jaegil Kim…·Nir Hacohen
The paper develops DNA- and RNA-based models combining immune and tumor features to predict outcomes of checkpoint inhibition in melanoma.